$4.86 -0.14 (-2.70%)
2/10/2012 4:00 PM

Santarus, Inc. (NASDAQ:SNTS)

CAPS Rating: 3 out of 5

A pharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by gastroenterologists or primary care physicians.

Featured Broker Partners


Advertisement